These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2055 related articles for article (PubMed ID: 28442273)

  • 1. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
    Chow MD; Lee YH; Guo GL
    Mol Aspects Med; 2017 Aug; 56():34-44. PubMed ID: 28442273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bile Acids in Nonalcoholic Fatty Liver Disease: New Concepts and therapeutic advances.
    Cruz-Ramón V; Chinchilla-López P; Ramírez-Pérez O; Méndez-Sánchez N
    Ann Hepatol; 2017 Nov; 16(Suppl. 1: s3-105.):s58-s67. PubMed ID: 29080343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear receptors and nonalcoholic fatty liver disease.
    Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
    Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile acid modulators for the treatment of nonalcoholic steatohepatitis (NASH).
    Fiorucci S; Biagioli M; Sepe V; Zampella A; Distrutti E
    Expert Opin Investig Drugs; 2020 Jun; 29(6):623-632. PubMed ID: 32552182
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circadian Homeostasis of Liver Metabolism Suppresses Hepatocarcinogenesis.
    Kettner NM; Voicu H; Finegold MJ; Coarfa C; Sreekumar A; Putluri N; Katchy CA; Lee C; Moore DD; Fu L
    Cancer Cell; 2016 Dec; 30(6):909-924. PubMed ID: 27889186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets.
    Cheng Z; Chen Y; Schnabl B; Chu H; Yang L
    J Adv Res; 2024 May; 59():173-187. PubMed ID: 37356804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives.
    Arab JP; Karpen SJ; Dawson PA; Arrese M; Trauner M
    Hepatology; 2017 Jan; 65(1):350-362. PubMed ID: 27358174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent insights into farnesoid X receptor in non-alcoholic fatty liver disease.
    Xu JY; Li ZP; Zhang L; Ji G
    World J Gastroenterol; 2014 Oct; 20(37):13493-500. PubMed ID: 25309079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bile acid and receptors: biology and drug discovery for nonalcoholic fatty liver disease.
    Jiao TY; Ma YD; Guo XZ; Ye YF; Xie C
    Acta Pharmacol Sin; 2022 May; 43(5):1103-1119. PubMed ID: 35217817
    [TBL] [Abstract][Full Text] [Related]  

  • 10. INT-767 improves histopathological features in a diet-induced
    Roth JD; Feigh M; Veidal SS; Fensholdt LK; Rigbolt KT; Hansen HH; Chen LC; Petitjean M; Friley W; Vrang N; Jelsing J; Young M
    World J Gastroenterol; 2018 Jan; 24(2):195-210. PubMed ID: 29375205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bile Acid Control of Metabolism and Inflammation in Obesity, Type 2 Diabetes, Dyslipidemia, and Nonalcoholic Fatty Liver Disease.
    Chávez-Talavera O; Tailleux A; Lefebvre P; Staels B
    Gastroenterology; 2017 May; 152(7):1679-1694.e3. PubMed ID: 28214524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A vicious circle between insulin resistance and inflammation in nonalcoholic fatty liver disease.
    Chen Z; Yu R; Xiong Y; Du F; Zhu S
    Lipids Health Dis; 2017 Oct; 16(1):203. PubMed ID: 29037210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of gut microbiota with dysregulation of bile acids in the pathogenesis of nonalcoholic fatty liver disease and potential therapeutic implications of probiotics.
    Chen J; Thomsen M; Vitetta L
    J Cell Biochem; 2019 Mar; 120(3):2713-2720. PubMed ID: 30443932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma.
    Kutlu O; Kaleli HN; Ozer E
    Can J Gastroenterol Hepatol; 2018; 2018():8543763. PubMed ID: 30228976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non alcoholic steatohepatitis a precursor for hepatocellular carcinoma development.
    Jiang CM; Pu CW; Hou YH; Chen Z; Alanazy M; Hebbard L
    World J Gastroenterol; 2014 Nov; 20(44):16464-73. PubMed ID: 25469014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excessive bile acid activated NF-kappa B and promoted the development of alcoholic steatohepatitis in farnesoid X receptor deficient mice.
    Wu WB; Chen YY; Zhu B; Peng XM; Zhang SW; Zhou ML
    Biochimie; 2015 Aug; 115():86-92. PubMed ID: 26025474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of FXR in Bile Acid and Metabolic Homeostasis in NASH: Pathogenetic Concepts and Therapeutic Opportunities.
    Radun R; Trauner M
    Semin Liver Dis; 2021 Nov; 41(4):461-475. PubMed ID: 34289507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease.
    Svegliati-Baroni G; Pierantonelli I; Torquato P; Marinelli R; Ferreri C; Chatgilialoglu C; Bartolini D; Galli F
    Free Radic Biol Med; 2019 Nov; 144():293-309. PubMed ID: 31152791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bile acid sequestration reverses liver injury and prevents progression of nonalcoholic steatohepatitis in Western diet-fed mice.
    Takahashi S; Luo Y; Ranjit S; Xie C; Libby AE; Orlicky DJ; Dvornikov A; Wang XX; Myakala K; Jones BA; Bhasin K; Wang D; McManaman JL; Krausz KW; Gratton E; Ir D; Robertson CE; Frank DN; Gonzalez FJ; Levi M
    J Biol Chem; 2020 Apr; 295(14):4733-4747. PubMed ID: 32075905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ileal bile acid uptake protects against nonalcoholic fatty liver disease in high-fat diet-fed mice.
    Rao A; Kosters A; Mells JE; Zhang W; Setchell KD; Amanso AM; Wynn GM; Xu T; Keller BT; Yin H; Banton S; Jones DP; Wu H; Dawson PA; Karpen SJ
    Sci Transl Med; 2016 Sep; 8(357):357ra122. PubMed ID: 27655848
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 103.